- A leap for the journal: Clinical and Molecular Hepatology enters a new era
-
Kim YJ
- KMID: 2467241
- Clin Mol Hepatol.
- 2019 Dec;25(4):333-334.
- doi: 10.3350/cmh.2019.1004
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
-
Cheng Z, Wang F, Liu J
- KMID: 2467253
- Clin Mol Hepatol.
- 2019 Dec;25(4):417-419.
- doi: 10.3350/cmh.2019.0030
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Persistent elevation of aminotransferases in liver transplant in association with chronic norovirus infection
-
Khayat AA, Telega GW
- KMID: 2467251
- Clin Mol Hepatol.
- 2019 Dec;25(4):408-411.
- doi: 10.3350/cmh.2019.0018
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists
-
Phowthongkum P, Suphapeetiporn K, Shotelersuk V
- KMID: 2467252
- Clin Mol Hepatol.
- 2019 Dec;25(4):412-416.
- doi: 10.3350/cmh.2018.0114
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
-
Parigi TL, Torres MC, Aghemo A
- KMID: 2467245
- Clin Mol Hepatol.
- 2019 Dec;25(4):360-365.
- doi: 10.3350/cmh.2019.0022
Despite the high efficacy of direct acting antivirals (DAAs) not all patients successfully clear hepatitis C virus infection, in fact, approximately 1–3% fail to reach a sustained virological response 12... -
- CITED
-
- Close
- SHARE
-
- Close
- Ultraselective conventional transarterial chemoembolization: When and how?
-
Miyayama S
- KMID: 2467243
- Clin Mol Hepatol.
- 2019 Dec;25(4):344-353.
- doi: 10.3350/cmh.2019.0016
Ultraselective conventional transarterial chemoembolization (cTACE), defined as cTACE at the most distal portion of the subsubsegmental hepatic artery, is mainly performed for hepatocellular carcinoma (HCC) ≤5 cm. Distal advancement of... -
- CITED
-
- Close
- SHARE
-
- Close
- Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
-
Yang JD
- KMID: 2467242
- Clin Mol Hepatol.
- 2019 Dec;25(4):335-343.
- doi: 10.3350/cmh.2019.0010
Very early stage hepatocellular carcinoma (HCC) is defined as a single tumor with the largest diameter of the lesion measuring 2 cm or less according to Barcelona Liver Cancer staging... -
- CITED
-
- Close
- SHARE
-
- Close
- Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
-
Moriya K, Namisaki T, Sato S, Furukawa M, Douhara A, Kawaratani H, Kaji K, Shimozato , Sawada Y, Saikawa S, Takaya H, Kitagawa K, Akahane T, Mitoro A, Yamao J, Yoshiji H
- KMID: 2467248
- Clin Mol Hepatol.
- 2019 Dec;25(4):381-389.
- doi: 10.3350/cmh.2019.0037
BACKGROUND AND AIMS: We previously reported the comparable efficacy of bi-monthly hepatic arterial infusion chemotherapy (B-HAIC) to that of sorafenib chemotherapy for the treatment of advanced hepatocellular carcinoma (aHCC) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?
-
Ahn KS, Kang KJ
- KMID: 2467244
- Clin Mol Hepatol.
- 2019 Dec;25(4):354-359.
- doi: 10.3350/cmh.2018.0096
There has been controversy regarding the first-line treatment modality for the patients who have small solitary hepatocellular carcinoma (HCC); radiofrequency ablation (RFA) or percutaneous ethanol injection (PEI), surgical hepatic resection... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and risk factors of dysphagia after variceal band ligation
-
Arasu S, Liaquat H, Suri J, Ehrlich AC, Friedenberg FK
- KMID: 2467247
- Clin Mol Hepatol.
- 2019 Dec;25(4):374-380.
- doi: 10.3350/cmh.2019.0019
BACKGROUND/AIMS: There is a lack of data on long-term morbidity, particularly dysphagia, following endoscopic variceal band ligation (EVL). The aim of this study are to assess the incidence of dysphagia... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
-
Laiwatthanapaisan R, Sripongpun P, Chamroonkul N, Dechaphunkul A, Sathitruangsak C, Sakdejayont S, Kongkamol , Piratvisuth T
- KMID: 2467246
- Clin Mol Hepatol.
- 2019 Dec;25(4):366-373.
- doi: 10.3350/cmh.2018.0111
BACKGROUND/AIMS: Hepatitis B virus reactivation (HBVr) following chemotherapy (CMT) is well-known among hematologic malignancies, and screening recommendations are established. However, HBVr data in solid organ malignancy (SOM) patients are limited.... -
- CITED
-
- Close
- SHARE
-
- Close
- An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
-
Lee YJ, Heo J, Kim DY, Chung WJ, Tak WY, Kim YJ, Paik SW, Sim E, Kulasingam S, Talwani R, Haber B, Hwang P
- KMID: 2467250
- Clin Mol Hepatol.
- 2019 Dec;25(4):400-407.
- doi: 10.3350/cmh.2019.0006
BACKGROUND/AIMS: In the Republic of Korea, an estimated 231,000 individuals have chronic hepatitis C virus (HCV) infection. The aim of the present analysis was to evaluate the safety and efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
-
Shin H, Jung YW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim YY, Choi JY, Kim SU
- KMID: 2467249
- Clin Mol Hepatol.
- 2019 Dec;25(4):390-399.
- doi: 10.3350/cmh.2018.0103
BACKGROUND/AIMS: A risk prediction model for the development of hepatocellular carcinoma (HCC) from indeterminate nodules detected on computed tomography (CT) (Rad(CT) score) in patients with chronic hepatitis B (CHB)-related cirrhosis... -
- CITED
-
- Close
- SHARE
-
- Close
